Biological Dynamics Appoints Zach Miller to Board of Directors
Retrieved on:
Tuesday, March 7, 2023
Science, Biotechnology, Research, Surgery, Oncology, Health, Clinical Trials, Other Health, Slate, Tiger Global Management, Philosophy, Biological Dynamics of Forest Fragments Project, Bain Capital, Worcester College, Oxford, University of Oxford, Growth, Miller, Pancreatic cancer, Partnership, Patient, Williams College, Information technology, Biology, Pharmaceutical industry
Biological Dynamics, Inc. , an emerging growth life sciences company commercializing its ExoVerita™ platform for exosome-isolation and ExoVita™ Pancreas assay for the early detection of pancreatic cancer, has appointed Zach Miller as a member of its Board of Directors.
Key Points:
- Biological Dynamics, Inc. , an emerging growth life sciences company commercializing its ExoVerita™ platform for exosome-isolation and ExoVita™ Pancreas assay for the early detection of pancreatic cancer, has appointed Zach Miller as a member of its Board of Directors.
- Miller will provide strategic guidance and direction for the Company as it enters a period of rapid growth and commercial operations.
- Miller holds a bachelor’s degree, summa cum laude, from Williams College and a master’s degree in philosophy with distinction from Worcester College, Oxford University.
- “I am honored to join Biological Dynamics’ Board of Directors and look forward to supporting the Company’s mission to provide groundbreaking diagnostic solutions for early disease detection,” Miller said.